BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Bayer Appoints Brenda L. Raphael Senior Vice President and General Manager of Therapeutics Business Unit for Consumer Health

  Bayer today announced the appointment of Brenda L. Raphael as Senior VP and General Manager of the Therapeutics Business Unit of Consumer Health Commercial Operations North America, effective October 30, 2017.

  October 17, 2017

   · 

  2 min read
• Transgene Presents First Clinical Data Indicating That TG1050 Induces A Robust And HBV-Specific Cell-Mediated Immune Response In Patients With Chronic Hepatitis B

  Transgene, a biotech company that designs and develops viral-based immunotherapies, will be presenting a poster on TG1050 first promising clinical results at the American Association for the Study of Liver Diseases (AASLD) Meeting 2017, in Washington, DC, October 20-24.

  October 17, 2017

   · 

  6 min read
• NRGene Technology Efficiently Analyzes Abnormalities in Multiple Human Genomes

  NRGene has demonstrated its ability to discover, analyze, and track abnormalities within the human genome, across multiple subjects.

  October 17, 2017

   · 

  2 min read
• Bio NC

  CEM Introduces the Future of Molecular Sample Preparation

  CEM is pleased to introduce the all new EDGE extraction system for rapid sample preparation of GC/LC samples.

  October 17, 2017

   · 

  2 min read
• Business

  Askbio and Columbus Venture Partners Launch Gene Therapy Company Viralgen

  Asklepios BioPharma announced the formation of Viralgen, a gene therapy joint venture with Columbus Venture Partners.

  October 17, 2017

   · 

  3 min read
• Drug Development

  Xenon Pharmaceuticals Announces Initiation of XEN1101 Phase I Clinical Trial

  Xenon’s innovative, proprietary epilepsy programs continue to advance in development.

  October 17, 2017

   · 

  8 min read
• Drug Development

  Immune Design Announces Positive FDA Feedback on Phase III Clinical Trial Design for CMB305 in Synovial Sarcoma Patients

  The company plans to initiate a pivotal Phase 3 trial to support a Biologics License Application for CMB305.

  October 17, 2017

   · 

  6 min read
• Drug Development

  Tonix Pharmaceuticals Reports Outcomes From U.S. FDA Breakthrough Therapy CMC Guidance Meeting of Tonmya (Cyclobenzaprine HCI Sublingual Tablets) for PTSD

  Tonix is in Phase 3 development of Tonmya, an FDA-designated Breakthrough Therapy for the treatment of PTSD.

  October 17, 2017

   · 

  5 min read
• Drug Development

  Inventiva’s Phase IIb FASST Trial In Systemic Sclerosis With Lanifibranor Completes Enrollment

  Inventiva announced that it has completed the enrollment of its Phase IIb FASST (For A Systemic Sclerosis Treatment) trial in Systemic Sclerosis (SSc) with lanifibranor, formerly known as IVA337.

  October 17, 2017

   · 

  3 min read
• Business

  Digirad Corporation to Release 2017 Third Quarter Financial Results on November 3, 2017

  Management will discuss financial results for the third quarter ended September 30, 2017.

  October 17, 2017

   · 

  1 min read